MARK MORMAN: Open Payments
NPI 1306955398 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 4 payments from 4 companies in 2025. Trend: 2023 $2,264 · 2024 $32 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Alkermes, Inc. | 1 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $101 |
| Teva Pharmaceuticals USA, Inc. | 1 | $36 |
Products named: INVEGA, LYBALVI, INGREZZA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
